Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.69	11.35	12.98	19.47	105.83	18.08
Short-Term Investments	49.73	64.33	110.22	61.78	-	-
Cash & Short-Term Investments	57.42	75.68	123.2	81.25	105.83	18.08
Cash Growth	-30.66%	-38.57%	51.63%	-23.23%	485.39%	48.93%
Accounts Receivable	32.96	40.8	38.06	29.2	18.57	14.49
Other Receivables	0.6	0.6	1.1	0.4	-	-
Receivables	33.56	41.4	39.16	29.6	18.57	14.49
Inventory	41.42	39.26	29.25	19.33	10.56	7.82
Prepaid Expenses	5.6	5.07	6.75	3.22	3.01	0.59
Total Current Assets	138	161.4	198.36	133.4	137.97	40.98
Property, Plant & Equipment	37.8	34.4	31.56	25.48	2.85	0.83
Goodwill	12.82	12.82	12.82	-	-	-
Other Intangible Assets	7.36	8.08	9.03	-	-	-
Other Long-Term Assets	0.61	0.41	0.15	0.15	-	-
Total Assets	196.59	217.09	251.91	159.02	140.82	41.81
Accounts Payable	16.1	10.52	11.84	8.67	4.06	2.27
Accrued Expenses	20.7	21.77	25.43	21.24	14.15	7.54
Current Portion of Long-Term Debt	-	-	-	-	-	1.79
Current Portion of Leases	2.12	0.41	1.4	0.34	-	-
Other Current Liabilities	0.19	2.22	6.37	-	-	-
Total Current Liabilities	40.91	34.93	45.03	30.25	18.21	11.6
Long-Term Debt	53.53	53.31	53.01	52.71	29.54	29.43
Long-Term Leases	12.93	15.93	15.89	15.54	-	-
Other Long-Term Liabilities	0.04	0.04	0.04	-	-	-
Total Liabilities	107.4	104.2	113.97	98.5	47.75	41.03
Common Stock	0.06	0.06	0.06	0.06	0.05	0.03
Additional Paid-In Capital	329.75	303	271.97	145.22	134.93	14.17
Retained Earnings	-239.6	-189.99	-134.25	-84.72	-41.91	-21.35
Treasury Stock	-1.11	-0.28	-0.01	-	-	-
Comprehensive Income & Other	0.08	0.1	0.16	-0.03	-	-
Total Common Equity	89.19	112.89	137.94	60.53	93.07	-7.16
Shareholders' Equity	89.19	112.89	137.94	60.53	93.07	0.78
Total Liabilities & Equity	196.59	217.09	251.91	159.02	140.82	41.81
Total Debt	70.37	69.65	70.3	68.59	29.54	31.22
Net Cash (Debt)	-12.96	6.02	52.9	12.66	76.3	-13.14
Net Cash Growth	-	-88.61%	317.71%	-83.40%	-	-
Net Cash Per Share	-0.21	0.10	0.87	0.23	1.58	-0.35
Filing Date Shares Outstanding	63.72	62.36	61.75	61.16	54.75	37.37
Total Common Shares Outstanding	63.7	62.36	61.75	55.63	54.18	37.37
Working Capital	97.09	126.48	153.33	103.16	119.76	29.38
Book Value Per Share	1.40	1.81	2.23	1.09	1.72	-0.19
Tangible Book Value	69.01	92	116.1	60.53	93.07	-7.16
Tangible Book Value Per Share	1.08	1.48	1.88	1.09	1.72	-0.19
Machinery	39.04	29.48	20.19	12.32	5.06	3.16
Construction In Progress	0.9	0.61	1.12	0.71	0.13	-
Leasehold Improvements	10.58	10.24	9.43	6.43	0.27	0.17

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q